inderal la

Generic: propranolol hydrochloride

Labeler: ani pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name inderal la
Generic Name propranolol hydrochloride
Labeler ani pharmaceuticals, inc.
Dosage Form CAPSULE, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

propranolol hydrochloride 160 mg/1

Manufacturer
ANI Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 62559-523
Product ID 62559-523_ca8f11e2-bf38-474e-9929-43c522be09ea
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA018553
Listing Expiration 2026-12-31
Marketing Start 2017-04-28

Pharmacologic Class

Classes
adrenergic beta-antagonists [moa] beta-adrenergic blocker [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62559523
Hyphenated Format 62559-523

Supplemental Identifiers

RxCUI
856460 856462 856481 856483 856535 856537 856569 856571
UPC
0362559521017 0362559523011 0362559522014 0362559520010
UNII
F8A3652H1V

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name inderal la (source: ndc)
Generic Name propranolol hydrochloride (source: ndc)
Application Number NDA018553 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 160 mg/1
source: ndc
Packaging
  • 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-523-01)
  • 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-523-30)
source: ndc

Packages (2)

Ingredients (1)

propranolol hydrochloride (160 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ca8f11e2-bf38-474e-9929-43c522be09ea", "openfda": {"upc": ["0362559521017", "0362559523011", "0362559522014", "0362559520010"], "unii": ["F8A3652H1V"], "rxcui": ["856460", "856462", "856481", "856483", "856535", "856537", "856569", "856571"], "spl_set_id": ["35d28979-36b1-4630-b85e-a44e0a443734"], "manufacturer_name": ["ANI Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-523-01)", "package_ndc": "62559-523-01", "marketing_start_date": "20170428"}, {"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62559-523-30)", "package_ndc": "62559-523-30", "marketing_start_date": "20240805"}], "brand_name": "INDERAL LA", "product_id": "62559-523_ca8f11e2-bf38-474e-9929-43c522be09ea", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Adrenergic beta-Antagonists [MoA]", "beta-Adrenergic Blocker [EPC]"], "product_ndc": "62559-523", "generic_name": "propranolol hydrochloride", "labeler_name": "ANI Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "INDERAL", "brand_name_suffix": "LA", "active_ingredients": [{"name": "PROPRANOLOL HYDROCHLORIDE", "strength": "160 mg/1"}], "application_number": "NDA018553", "marketing_category": "NDA", "marketing_start_date": "20170428", "listing_expiration_date": "20261231"}